# OnCo record paper-gap-phase2-mdacc-jama-oncol-2019 (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-gap-phase2-mdacc-jama-oncol-2019/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-gap-phase2-mdacc-jama-oncol-2019" ;
  schema:name "Gemcitabine, Cisplatin, and nab-Paclitaxel for the Treatment of Advanced Biliary Tract Cancers: A Phase 2 Clinical Trial"@en ;
  schema:description "Published report from the cisplatin and nab-paclitaxel phase 2 trial registered as NCT02392637, in JAMA Oncology (2019), chosen as the most cited paper whose own text cites the registry id."@en ;
  schema:url <https://onco.cc/key-papers/paper-gap-phase2-mdacc-jama-oncol-2019/> ;
  schema:dateModified "2026-09-24"^^xsd:date ;
  schema:citation <https://doi.org/10.1001/jamaoncol.2019.0270>, <https://pubmed.ncbi.nlm.nih.gov/30998813/>, <https://europepmc.org/article/MED/30998813>, <https://clinicaltrials.gov/study/NCT02392637> ;
  onco:tag "europepmc-ingest" ;
  schema:sameAs <https://doi.org/10.1001/jamaoncol.2019.0270> ;
  schema:datePublished "2019"^^xsd:gYear ;
  schema:author "Shroff RT, Javle MM, Xiao L, et al." ;
  onco:trials <https://onco.cc/trials/gap-phase2-mdacc/> ;
  onco:journals <https://onco.cc/journals/jama-oncology/> .